The current and future burden of cancer attributable to modifiable risk factors in Canada: Summary of results-Reference-Cited by-同舟云学术

The current and future burden of cancer attributable to modifiable risk factors in Canada: Summary of results

Published:2019-05 Issue: Volume:122 Page:140-147
ISSN:0091-7435
Container-title:Preventive Medicine
language:en
Short-container-title:Preventive Medicine

Author:

Poirier Abbey E.,Ruan Yibing,Volesky Karena D.,King Will D.,O'Sullivan Dylan E.,Gogna Priyanka,Walter Stephen D.,Villeneuve Paul J.,Friedenreich Christine M.,Brenner Darren R.

Funder

Canadian Cancer Society

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Epidemiology

Reference25 articles.

1. The causes of cancer in France;Boniol;Ann. Oncol.,2008

2. Estimating the current and future cancer burden in Canada: methodological framework of the Canadian population attributable risk of cancer (ComPARe) study;Brenner;BMJ Open,2018

3. The burden of cancer attributable to modifiable risk factors in Canada: methodological overview;Brenner;Prev. Med.,2019

4. Estimates of the current and future burden of cancer attributable to excess body weight and abdominal adiposity in Canada;Brenner;Prev. Med.,2019

5. Canadian Cancer Statistics 2017 [Internet],2017

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geographical Disparities in Colorectal Cancer in Canada: A Review;Current Oncology Reports;2024-07-29

2. Assessing the effectiveness of “BETTER Women”, a community-based, primary care-linked peer health coaching programme for chronic disease prevention: protocol for a pragmatic, wait-list controlled, type 1 hybrid effectiveness-implementation trial;BMJ Open;2024-07

3. Chasing cancer: does the social-to-medical spending ratio relate to cancer incidence and mortality in Canadian provinces? A retrospective cohort study;BMJ Public Health;2024-07

4. Gastric and colorectal cancer incidence attributable to dietary factors in Korea;Journal of Gastrointestinal Oncology;2024-06